Introduction {#sec1-1}
============

Patients undergoing cardiac implantable electronic device (CIED) insertions have substantially increased, due to extended indications and improvement in device design with better outcomes, especially in the geriatric population. The unique challenge to the anesthesiologist during implantation of these devices are mainly operational. These patients also have compromised cardiovascular function. Hence, providing optimal sedation, adequate analgesia, and patient immobility are crucial to perform the procedure while maintaining stable hemodynamics.\[[@ref1]\]

Placement of these devices under local anesthetic infiltration frequently leads to inadequate analgesia and frequent movement of the patient during the procedure. Anesthetic techniques such as general anesthesia (GA) and monitored anesthesia care (MAC) with sedation may be risky in debilitating patients.\[[@ref2]\] Thoracic epidural and para-vertebral blocks (PVB) are extensively practiced for chest wall procedures. However, the thoracic epidural technique is associated with sympathectomy which may not be tolerated in geriatric population with compromised cardiovascular function. Despite the fact that PVB is associated with fewer hemodynamic alterations, there is a steep learning curve since they are technically challenging with the risk of accidental vascular, pleural, and neuraxial injury.\[[@ref3]\]

Blanco *et al*., introduced the pectoral nerve block (PECS1), as an alternative analgesic technique for breast conservative surgeries.\[[@ref4]\] Since then, various studies showed this technique to be useful in providing adequate analgesia for chest wall procedures.\[[@ref5]\] PECS1 block targets medial and lateral pectoral nerves in the plane between the pectoralis major and pectoralis minor. It provides analgesia related to surgical disruption of pectoral muscles and related fascial structures.

There are case reports on PECS with transversus thoracis muscle (TTM) block and PECS with intercostal nerve block for effective analgesia in patients undergoing modified radical mastectomy and CIED insertion, respectively.\[[@ref6][@ref7]\] TTM is also used in combination with parasternal block to treat the residual post-thoracotomy pain syndrome.\[[@ref8]\] There has been limited literature on the combination of PECS1 with a TTM block for CIED insertion procedures. Hence, the present study was conducted to compare the analgesic efficacy of PECS1 block with combined PECS1 and TTM block in patients undergoing CIED insertion.

Objective of the study {#sec2-1}
----------------------

To compare the analgesic efficacy of PECS1 block with combined PECS1 and TTM blocks for CIED insertion.

Materials and Methods {#sec1-2}
=====================

After the approval from the Institutional Ethics Committee and written informed consent, 30 patients (15 in each group) were enrolled in the study.

Inclusion criteria were adult patients between 18--85 years, scheduled for elective CIED insertion.

Exclusion criteria were a refusal of consent by the patient, allergy to local anesthetics, bleeding diathesis, chest wall deformities, and rib fractures.

Patients were randomized by computer-generated random table into two groups, namely, PECS1 (Group P) and combined PECS1 and TTM block group (Group PT). The subjects in both groups were explained about pain scoring based on the visual analog scale (VAS).

On the day of the procedure, intravenous access was secured. Pulse oximetry, electrocardiography, and noninvasive blood pressure monitoring were established. In both groups, the patients were premedicated with midazolam 0.5 mg intravenously. Oxygen via a simple face mask was supplemented at the rate of 6--8 L/min.

Under strict aseptic precautions, an in-plane approach using high frequency 12 MHz linear ultrasound transducer (Philips En Visor CHD, Bothell, Washington, USA 98041) was used to perform the blocks.

In group P, PECS1 block was performed after placing the transducer obliquely over the infraclavicular (pectoral) region at the level of the third rib. The skin was infiltrated locally with 2 ml of 1% lignocaine over the needle insertion site. From lateral edge of the transducer, 23G Quincke\'s needle was inserted deep to pectoralis major and superficial to pectoralis minor and hydro-dissection was demonstrated in the interfascial plane using injection of 3--5 ml of saline after confirming negative aspiration for blood and air \[[Figure 1](#F1){ref-type="fig"}\]. A bolus dose of 0.25% bupivacaine 10 ml was administered.

![Sonoanatomy showing needle path while performing PECS1 block](ACA-23-165-g001){#F1}

Patients in group PT (PECS1 and TTM) were administered with both PECS1 and TTM blocks. Under strict aseptic precautions, the PECS1 block was performed in a similar technique to group P and a bolus dose of 0.25% bupivacaine 10 ml was administered. TTM block was performed on the same side by placing transducer horizontally lateral to the sternum at the level of third intercostal space. A 21G hypodermic needle was inserted from lateral to medial direction after skin infiltration with 2 ml of 1% lignocaine. After placing the needle tip deep to intercostal muscles and superficial to transversus thoracic muscle, hydro dissection and/or downward displacement of pleura were demonstrated using injection of 3--5 ml saline, after confirming negative aspiration for blood or air \[[Figure 2](#F2){ref-type="fig"}\]. A bolus dose of 0.25% bupivacaine 10 ml was administered.

![Sonoanatomy showing hydro dissection while performing TTM block](ACA-23-165-g002){#F2}

About 5 ml of 1% lignocaine was infiltrated over the skin incision site in both the groups.

During the intraoperative period, any perception of pain over the procedural site was treated with an additional 2 ml of 1% lignocaine infiltration locally by the operating cardiologist. The volume of additional lignocaine infiltration required was noted.

Level of sedation in either group was assessed with Ramsay Sedation Scale (RSS: 1-anxious, agitated, restless; 2-oriented, tranquil; 3-responds to commands; 4- brisk response to glabellar tap; 5- sluggish response to glabellar tap; 6-no response).

If RSS was 1, an additional 0.5 mg of midazolam was administered intravenously. The total dosage of supplemental midazolam was also noted.

After the surgical procedure, patients were shifted to the postoperative cardiac catheterization observation unit.

VAS score was used to assess pain postoperatively. VAS score at rest and during a cough or deep breathing were assessed after the procedure at 0 h, 3 h, 6 h, 12 h, and 24 h. The severity of pain was classified as mild (VAS 0--4), moderate (VAS 5--7), and severe (VAS 8--10).

Breakthrough pain was defined as a VAS score of 4 or more at rest or on patient\'s demand. IV paracetamol 15 mg/kg was administered as first rescue analgesic.

If the VAS score was persistently 4 or more after 30 min of first rescue analgesia, IV tramadol 1 mg/kg was administered slowly as second rescue analgesia.

Dynamic pain was defined as the difference in VAS score between rest and cough of \>2 points.

The total consumption of first and second rescue analgesics was noted.

Statistical analysis {#sec2-2}
--------------------

The normal distribution of the data was confirmed by the Shapiro-Francia test. Parametric data were expressed as mean ± SD, nonparametric data as median and range. An independent student *t*-test was used to compare continuous data between the two groups. Categorical data were assessed using Chi-square test. *P* value \<0.05 was considered statistically significant. Statistical analysis was done using Medcalc software version 12.2.1.0 (Ostend, Belgium).

Results {#sec1-3}
=======

All 30 patients completed the study protocol. Patients in both groups were comparable for demographic characteristics, including age, gender, and duration of the procedure \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographic variables

                                            Group P (*n*=15)   Group PT (*n*=15)   *P*
  ----------------------------------------- ------------------ ------------------- -------
  Age (years) \[Mean±SD\]                   67.8±15.08         67.13±14.08         0.9
  Gender                                                                           
   Male                                     7                  7                   1.0
   Female                                   8                  8                   
  Height (cm) (Mean ±SD)                    164.90±6.85        167.57±4.97         0.090
  Weight (kg) (Mean ±SD)                    57.80±9.25         57.00±9.64          0.744
  Duration of procedure (min) \[Mean±SD\]   72.66±7.98         68.66±8.33          0.1

SD: Standard Deviation, min: Minutes, cm: Centimetre, kg: Kilogram

VAS score at rest \[[Table 2a](#T2){ref-type="table"}\] and during deep breathing or cough \[[Table 2b](#T3){ref-type="table"}\] were recorded at 0 h, 3 h, 6 h, 12 h, and 24 h after completion of the procedure. VAS scores at rest were significantly lower in group PT patients at 0 h, 3 h, 6 h, and 12 h (*P* \< 0.05). At 24 h, VAS scores at rest were comparable between the two groups (*P* = 0.22). Pain scores during deep breathing or cough were also significantly low at 0 h, 6 h, and 12 h in group PT than group P (*P* \< 0.05). At 24 h, VAS scores during cough were comparable between the two groups (*P* = 0.54).

###### 

VAS score at rest

  Time                 VAS score at rest   *P*          
  -------------------- ------------------- ------------ ----------
  VAS-0 (mean±SD)      2.6±1.59            1.0±0.92     0.002\*
  VAS-3 (median±IQR)   3 (2 to 3)          1 (1 to 2)   0.006\*
  VAS-6 (mean±SD)      3.66±0.28           2.2±1.01     0.0008\*
  VAS-12 (mean±SD)     5.0±0.43            2.8±0.29     0.0003\*
  VAS-24 (mean±SD)     3.4±1.18            3.0±0.37     0.22

SD: Standard deviation, IQR: Interquartile range, VAS: Visual analog scale. \*Statistically significant

###### 

VAS score during deep breathing or cough

  Time     VAS score during deep breathing or cough   *P*         
  -------- ------------------------------------------ ----------- ----------
  VAS-0    2.66±1.54                                  1.2±1.14    0.006\*
  VAS-3    2.86±0.74                                  2.2±1.61    0.15
  VAS-6    4.0±1.41                                   2.7±1.09    0.01\*
  VAS-12   5.53±1.99                                  3.13±1.35   0.0006\*
  VAS-24   3.4±1.18                                   3.2±0.41    0.54

Values are Mean±SD, SD: Standard deviation, VAS: Visual analog scale. \*Statistically significant

The number of patient that required first rescue analgesia was significantly high in group P as compared to group PT (13 in group P vs 3 in group PT, *P* = 0.0003) \[[Table 3a](#T4){ref-type="table"}\]. Total consumption of first rescue analgesia was significantly higher in group P (1400.0 ± 910.25) than the group PT (266.66 ± 593.61) (*P* = 0.0004) \[[Table 3b](#T5){ref-type="table"}\].

###### 

Number of patients requiring analgesia

                                      Group P (*n*=15)   Group PT (*n*=15)   *P*
  ----------------------------------- ------------------ ------------------- ----------
  Local anaesthetic supplementation   14                 1                   0.0001\*
  First rescue analgesia              13                 3                   0.0003\*
  Second rescue analgesia             4                  1                   0.14

\*Statistically significant

###### 

Total consumption of sedation/rescue analgesia

                                          Total consumption of sedation/rescue Analgesia   *P*             
  --------------------------------------- ------------------------------------------------ --------------- ----------
  Intraoperative midazolam (mg)           0.46±0.44                                        0.06±0.17       0.002\*
  Intraoperative local anaesthetic (ml)   2.53±1.35                                        0.66±2.58       0.01\*
  First rescue analgesia (mg)             1400.0±910.25                                    266.66±593.61   0.0004\*
  Second rescue analgesia (mg)            13.33±22.88                                      3.33±12.90      0.15

Values are Mean±SD. SD: Standard deviation. Mg: Milligrams, ml: Millilitres. *P* =\< 0.05 is statistically significant

Second rescue analgesia was administered in four patients in group P as compared to only one patient in group PT (*P* = 0.14). Total requirement of second rescue analgesia was comparable between two groups (group P 13.33 ± 22.88 mg vs 3.33 ± 12.90 mg in group PT) (*P* = 0.15) \[[Table 3b](#T5){ref-type="table"}\].

Local anaesthetic supplementation was administered to 14 patients in group P as compared to only one patient in group PT (*P* = 0.0001) \[[Table 3a](#T4){ref-type="table"}\]. Total requirement of additional local anaesthetic was significantly higher in group P (2.53 ± 1.35) as compared to group PT (0.66 ± 2.58) (*P* = 0.01) \[[Table 3b](#T5){ref-type="table"}\].

Total requirement of midazolam was significantly higher in group P (0.46 ± 0.44) as compared to group PT (0.06 ± 0.17). (*P* = 0.002) \[[Table 3b](#T5){ref-type="table"}\].

Ramsay sedation score at 5 min was significantly lower in group P (1.4 ± 0.5) as compared to group PT (2.4 ± 1.06) (*P* = 0.001). At 30 and 60 min, it was higher in group P as compared to group PT (*P* \< 0.05) \[[Table 3c](#T6){ref-type="table"}\].

###### 

Ramsay sedation score

  Time     Ramsay Sedation Score   *P*         
  -------- ----------------------- ----------- ---------
  5 min    1.4±0.5                 2.4±1.06    0.001\*
  30 min   3.46±1.12               2.46±1.06   0.01\*
  60 min   3.2±1.08                2.4±0.63    0.01\*

\*Statistically significant

Discussion {#sec1-4}
==========

Pain and patient discomfort following interventional electrophysiological procedures are vastly underestimated. Although routine local infiltration at the procedural site provides analgesia, it frequently interrupts the procedure and the effect is short-lasting. Any undertreated pain will lead to emotional stress which in turn results in negative immune-modulating effects and cognitive dysfunction postoperatively.\[[@ref9]\] Bode *et al*. highlighted the high prevalence (60%) of postprocedural pain in the first 24 h following cardiac device surgical procedures.\[[@ref10]\]

Bollman *et al*. showed that 86% of patients who underwent subpectoral ICD implantation under conscious sedation had a mean VAS score of 34 ± 20 at 24 h after the procedure.\[[@ref11]\] Chronic shoulder pain and disability were described in 54% of patients for more than 3 years after ICD implantation.\[[@ref12]\]

These findings enlighten the fact that properly structured multimodal analgesia is needed to address these issues. In the paradigm of enhanced recovery after surgery (ERAS), site-specific regional anesthesia is evolving as an adjunct to opioid-sparing strategies.

Tsai *et al*. observed that thoracic paravertebral block with sedation provided good analgesia in a 51-year-old male scheduled for removal of infected ICD and laser lead extraction.\[[@ref13]\] But it has inherent risks associated with it in anticoagulated patients and demands more technical expertise. In contrast, truncal plane blocks are relatively easy to perform and provide excellent analgesia with a good safety profile.\[[@ref14]\]

Fujiwara *et al*. administered PECS with intercostal nerve block for cardiac resynchronization therapy (CRT-D) implantation and found it to be an effective analgesic technique.\[[@ref7]\] However, intercostal nerve block has to be administered at multiple sites causing discomfort to the patient. In contrast, the TTM block targets anterior branch of T2-T6 intercostal nerves, hence a single injection for TTM block is usually suffice.

Ali Hassn *et al*. administered ultrasound-guided PECS block using dexmedetomidine and bupivacaine in patients with chronic postmastectomy pain. They noted that lower VAS scores in the first 24 h after surgery, reduced chronic pain on follow up, and better patient satisfaction.\[[@ref15]\]

Since PECS block doesn\'t provide adequate analgesia for procedures extending to the internal mammary area, Ueshima *et al*. conducted a study on patients undergoing mastectomy under GA wherein PECS block alone was compared with combined PECS and TTM block. They found lower VAS scores both at rest and during movement in combined PECS and TTM block groups.\[[@ref16]\]

In the present study, the VAS score at rest was significantly lower in patients who received combined PECS1 and TTM blocks (group PT) at 0, 3, 6, and 12 h (*P* \< 0.05). VAS scores during deep breathing or cough were also lower in the combined PECS1 and TTM blocks group (group PT) compared to PECS1 block alone (group P) with statistical significance at 0, 6, and 12 h (*P* \< 0.05).

This was reflected by a five-fold increase in the use of first rescue analgesia in the PECS group as compared to combined PECS and TTM blocks. Thirteen patients in group P received first rescue analgesia compared to three patients in group PT, with most of the patients requiring at around the twelfth hour.

Elamaym *et al*. compared combined GA and PECS plus TTM blocks with GA alone in patients undergoing radical mastectomy and showed better analgesia and reduced opioid consumption intraoperatively in the PECS plus TTM blocks group (285.6 ± 76.2 vs 345.3 ± 120.9) (*P* = 0.006).\[[@ref6]\]

In the present study, 14 patients in group P received local anaesthetic supplementation compared to only one patient in group PT \[P = 0.0001\] and the net consumption of local anaesthetic also reduced in group PT \[0.66 ± 2.58\] versus group P \[2.53 ± 1.35\], (*P* = 0.01). Both were statistically significant.

Total consumption of midazolam was higher in group P (0.46 ± 0.44) than group PT (0.06 ± 0.17), which is statistically significant (*P* = 0.002).

None of the patients in either group had complications related to the block procedures such as pneumothorax, local anesthetic systemic toxicity, hematoma, and so on.

Limitations {#sec2-3}
-----------

We did not follow up with the patients after discharge to assess chronic pain.

Probably a larger sample size would have revealed any complications associated with these blocks.

Conclusion {#sec1-5}
==========

Combined PECS1 and TTM blocks can provide superior analgesia, reduced net consumption of local anesthetic, sedative agents, and rescue analgesics compared to PECS1 block alone in patients undergoing CIED insertion.

Financial support and sponsorship {#sec2-4}
---------------------------------

Nil.

Conflicts of interest {#sec2-5}
---------------------

There are no conflicts of interest.
